95-23678. Advisory Committee on the Medical Uses of Isotopes: Meeting Notice

[Federal Register Volume 60, Number 185 (Monday, September 25, 1995)]
[Notices]
[Page 49428]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-23678]



=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission will convene its next 
regular meeting of the Advisory Committee on the Medical Uses of 
Isotopes (ACMUI) on October 18 and 19, 1995. The meeting will take 
place at the address provided below. All sessions of the meeting will 
be open to the public, except where specifically noted otherwise.
    Topics of discussion will include: (1) the role of the medical 
consultant; (2) Process of ACMUI review of training and experience 
exemptions; (3) intravascular brachytherapy issues; (4) discussion of 
NUREGs on human factors evaluations of teletherapy and brachytherapy; 
(5) discussion of petition for rulemaking for the commercial 
distribution of byproduct material for in vivo testing; (6) report on 
subcommittee review of draft licensing modules; (7) status report on 
National Academy of Science study; (8) update on rulemakings and 
regulatory guides; (9) discussion of STEP device; and (10) discussion 
of a manual chapter on patient follow-up.
    In addition, a portion of this meeting may be closed, to avoid the 
disclosure of information that would constitute an unwarranted invasion 
of the personal privacy of a physician whose training and experience 
will be reviewed by ACMUI in connection with the physician's 
application to be an authorized user under a license authorizing 
medical use of byproduct material.

DATES: The meeting will begin at 8:30 a.m., on October 18 and 19, 1995.

ADDRESSES: U.S. Nuclear Regulatory Commission, Two White Flint North, 
11545 Rockville Pike, Room T2B3, Rockville, MD 20852-2738.

FOR FURTHER INFORMATION, CONTACT: Josephine M. Piccone, Ph.D., U.S. 
Nuclear Regulatory Commission, Office of Nuclear Material Safety and 
Safeguards, MS T8F5, Washington, DC 20555, Telephone [phone]. 
For administrative information, contact Torre Taylor, [phone].

Conduct of the Meeting

    Barry Siegel, M.D., will chair the meeting. Dr. Siegel will conduct 
the meeting in a manner that will facilitate the orderly conduct of 
business. The following procedures apply to public participation in the 
meeting:
    1. Persons who wish to provide a written statement should submit a 
reproducible copy to Josephine M. Piccone (address listed above). The 
transcript of the meeting will be kept open until October 20, 1995, for 
inclusion of written comments.
    2. Persons who wish to make oral statements should inform Dr. 
Piccone in writing, by October 10, 1995. Statements must pertain to the 
topics on the agenda for the meeting. Members of the public will be 
permitted to make oral statements if time permits. Permission to make 
oral statements will be at the discretion of the Chairman and will be 
based on the order in which requests are received. In general, oral 
statements will be limited to approximately 5 minutes. For information 
regarding oral statements by members of the public, the order of 
presentation, and time allotments, call Dr. Piccone, [phone], 
between 8 a.m. and 4 p.m., EST, on October 16, 1995.
    3. At the meeting, questions from members of the public will be 
permitted at the discretion of the Chairman.
    4. The transcript and written comments will be available for 
inspection, and copying, for a fee, at the NRC Public Document Room, 
2120 L Street N.W., Lower Level, Washington, DC 20555 [phone], 
on or about November 3, 1995. Minutes of the meeting will be available 
on or about November 24, 1995.
    5. Seating for the public will be on a first-come, first-served 
basis.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in Title 
10, U.S. Code of Federal Regulations, Part 7.

    Dated: September 19, 1995.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 95-23678 Filed 9-22-95; 8:45 am]
BILLING CODE 7590-01-P